Filing Flows › Biomerica (BMRA) › Q4 FY25
Biomerica (BMRA) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Aug 29, 2025
Biomerica (BMRA) reported revenue of $749K for the fourth quarter fiscal 2025 (Q4 FY25), -33% from a year earlier and -33% from the quarter before. Operating margin was -208.8%, net loss $1.5M (206.1% of revenue).
Biomerica, Q4 FY25: revenue $749K (-33% year over year), operating margin -208.8%, net loss $1.5M, operating cash flow −$662K. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $749K | -33% | -33% |
| Operating profit | −$1.6M | — | — |
| Net earnings | −$1.5M | — | — |
| Operating cash flow | −$662K | — | — |
What changed
Revenue was $749K in Q4 FY25, down 33% year over year and down 33% from the previous quarter.
Operating costs exceeded revenue by $1.6M, an operating margin of -208.8%. The quarter ended with a net loss of $1.5M, wider than the previous quarter's $1.2M loss.
Operating cash flow was −$662K. Non-cash charges added back $23K of depreciation and amortization and $108K of share-based compensation. Working capital and other items added $751K.
Questions
What was Biomerica's revenue in the fourth quarter fiscal 2025?
Biomerica (BMRA) reported revenue of $749K for the fourth quarter fiscal 2025 (Q4 FY25), -33% from a year earlier and -33% from the quarter before.
Was Biomerica profitable in the fourth quarter fiscal 2025?
Operating loss was $1.6M (-208.8% of revenue) and net loss $1.5M.
Source: Biomerica 10-K on SEC EDGAR.